COVID-19 Update: Bharat Biotech releases third phase trial result, COVAXIN effective up to 81%
Indian company Biotech has released the data for the third phase trial of its CORONA vaccine (COVAXIN). It has claimed that the vaccine is 81% effective.
Written By: Zee Business Video Team